Effect of Submucosal Cryotherapy on Postoperative Endodontic Pain
Conditions: Post-endodontic Pain Interventions: Procedure: Cryotherapy; Procedure: Diclofenac sodium; Procedure: Dexamethasone sodium phosphate Sponsors: Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
Pericapsular Nerve Group Block Chemical Neurolysis in Advanced Hip Osteoarthritis
Conditions: Osteoarthritis; Osteoarthritis, Hip Interventions: Drug: 0.9%sodium chloride; Drug: 95% ethanol Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
The Impact of Genicular Nerves Chemical Neurolysis on the Quality of Life of Patients With Advanced Knee Osteoarthritis.
Conditions: Osteo Arthritis Knee; Osteoarthritis Interventions: Drug: 0.9% Sodium chloride; Drug: 95% ethanol Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials
Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery
Conditions: Ankle Disease; Ankle Injuries; Foot Injury; Foot Diseases Interventions: Drug: 0.9 % Sodium Chloride; Drug: 0.1mg/kg Dexamethasone; Drug: 0.05mg/kg Dexamethasone Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
Pain Management After Adductor Canal Block for Total Knee Arthroplasty
Conditions: Knee Osteoarthritis; Knee Arthritis; Knee Arthropathy; Knee Pain Chronic Interventions: Drug: Ropivacaine 0.2% Injectable Solution; Drug: 0.9%sodium chloride Sponsors: Poznan University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery
Conditions: Scoliosis Idiopathic; Scoliosis; Adolescence Interventions: Drug: 0.9% sodium chloride; Drug: Dexamethasone; Drug: Dexmedetomidine Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials
Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment
Conditions: Ureter Injury Interventions: Other: Saline Injection 0.9%; Drug: Indigotindisulfonate sodium 0.8% Sponsors: Prove pharm Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
Conditions: Brain Injuries, Acute; Brain Injuries, Traumatic; Brain Ischemia; Brain Hypoxia; Hypoxia-Ischemia, Brain; Heart Arrest; Stroke; Intracranial Hemorrhages; Coma; Persistent Vegetative State Interventions: Drug: Phenobarbital Sodium Injection; Drug: Levetiracetam; Drug: Lacosamide Injectable Product; Drug: Valproate Sodium; Drug: Phosphenytoin Sponsors: University of North Carolina, Chapel Hill Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
Conditions: Platelets-rich Plasma; Osteoarthritis Knees Both; Meniscus Disorder; Cartilage Injury Interventions: Drug: Sodium hyaluronate injection Sponsors: Xijing Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants
Conditions: Helicobacter Pylori Infection Interventions: Drug: TNP-2198; Drug: Rabeprazole Sodium; Drug: Amoxicillin Sponsors: TenNor Therapeutics (Suzhou) Limited Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules
Conditions: Helicobacter Pylori Infection Interventions: Drug: TNP-2198; Drug: Rabeprazole Sodium; Drug: Amoxicillin Sponsors: TenNor Therapeutics (Suzhou) Limited Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
Conditions: Early-Onset Neonatal Sepsis Interventions: Drug: Piperacillin Sodium and Tazobactam Sodium for Injection Sponsors: Shandong University; Shandong Provincial Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2023 Category: Research Source Type: clinical trials
Dosing of LT4 in Older Individuals
Conditions: Hypothyroidism Interventions: Drug: Levothyroxine Sodium Sponsors: University of Pennsylvania; National Institute on Aging (NIA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial
DiscussionThe present study will be the first trial to evaluate the efficacy and safety of early treatment with the combination of standard-dose empagliflozin and colchicine as well as high-dose empagliflozin in non-diabetic patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction. The results of this research will represent a significant step forward in the treatment of patients with acute myocardial infarction.Trial registrationClinical trial ID: IRCT20111206008307N39. Registration date: 27 October 2022.Graphical Abstract (Source: Trials)
Source: Trials - October 6, 2023 Category: Research Source Type: clinical trials
Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
Conditions: Medium-chain Acyl-CoA Dehydrogenase Deficiency Interventions: Drug: Sodium phenylbutyrate Sponsors: Jerry Vockley, MD, PhD; Acer Therapeutics Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
